Related Experiment Videos
Consensus statement of the Canadian MS CLinics Network on: the use of disease modifying agents in multiple sclerosis
1Canadian MS Clinics Network, Canada.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Persistent Cutibacterium (Formerly Propionibacterium) acnes Bacteremia and Refractory Endocarditis in a Patient with Retained Implantable Pacemaker Leads.
Case reports in infectious diseases·2020
Radiologically isolated syndrome: watchful waiting vs. active treatment.
Expert review of neurotherapeutics·2016
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Beta-interferon exposure and onset of secondary progressive multiple sclerosis.
European journal of neurology·2015
Effect of alveolar bone support on zygomatic implants in an extra-sinus position--a finite element analysis study.
International journal of oral and maxillofacial surgery·2015
A Comparison of Machine Learning Models for ICH Prognostication: An Analysis of ATACH-2 and Qatar Stroke Database.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Cerebral Microbleeds and Superficial Siderosis: Vascular Correlates and Cognition in a Memory Clinic.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Symptom Trajectories and Postoperative Treatment Response After Surgical Repair of Spinal CSF Leaks.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Challenges and Care Recommendations of Persons with Functional Neurological Disorder and Care Partners: A Qualitative Study.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026